SCHEMBL18644562

SCHEMBL18644562

CCOc1cc(C)c2c(c1)OCCCN2

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PARP1 P09874 5/20 0.38
▸ ALDH1A1 P00352 2/20 0.34
▸ MAPT P10636 2/20 0.34
▸ THRB P10828 1/20 0.34
▸ MEN1 O00255 1/20 0.33
▸ KMT2A Q03164 1/20 0.33
▸ CHEK1 O14757 1/20 0.32
▸ NPC1 O15118 2/20 0.32
▸ RAB9A P51151 2/20 0.32
▸ HSP90AA1 P07900 1/20 0.32
▸ RXFP1 Q9HBX9 1/20 0.31
▸ KDM4E B2RXH2 1/20 0.30
▸ LMNA P02545 1/20 0.30
▸ GLA P06280 1/20 0.30
▸ GAA P10253 1/20 0.30
▸ HPGD P15428 1/20 0.30
▸ CASP1 P29466 1/20 0.30
▸ CASP7 P55210 1/20 0.30
▸ HSD17B10 Q99714 1/20 0.30
▸ SMN1; SMN2 Q16637 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18644586 0.96 PARP1 (0.38) PARP1ALDH1A1MAPTTHRBMEN1
SCHEMBL18645735 0.85 THRB (0.34) PARP1ALDH1A1MAPTTHRBMEN1
SCHEMBL18644574 0.80 BRD4 (0.35) LMNA
SCHEMBL18645512 0.77 ALDH1A1 (0.39) ALDH1A1MAPTMEN1KMT2AKDM4E
SCHEMBL18644585 0.75 BRD4 (0.37) ALDH1A1MAPTLMNAGAAHSD17B10
SCHEMBL18644592 0.72 ALDH1A1 (0.38) ALDH1A1MAPTMEN1KMT2AKDM4E
SCHEMBL18645482 0.70 KDM4E (0.39) ALDH1A1NPC1RAB9AKDM4EHPGD
SCHEMBL18644579 0.67 PIK3CA (0.35) —
SCHEMBL3001705 0.67 MAP3K14 (0.41) PARP1ALDH1A1MAPTMEN1KMT2A
SCHEMBL18645499 0.67 PARP1 (0.38) PARP1CHEK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017042182-A1 TRICYCLIC PI3K INHIBITOR COMPOUNDS AND METHODS OF USE F. HOFFMANN-LA ROCHE AG (CH) 2017-03-16 — — WO disclosed
Send feedback